Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 30 | 39 | 29 | 5 | 0 |
| Cost of Goods | 1 | 2 | N/A | N/A | N/A |
| Gross Profit | 29 | 37 | 29 | 5 | N/A |
| Operating Expenses | 2,638 | 3,425 | 3,125 | 3,685 | 4,115 |
| Operating Income | -2,608 | -3,386 | -3,096 | -3,680 | -4,115 |
| Other Income | 59 | 44 | 51 | 76 | 121 |
| Pre-tax Income | -2,549 | -3,342 | -3,045 | -3,604 | -3,994 |
| Income Tax | N/A | 2 | -4 | N/A | N/A |
| Net Income Continuous | -2,549 | -3,344 | -3,041 | -3,604 | -3,994 |
| Net Income | $-2,549 | $-3,344 | $-3,041 | $-3,604 | $-3,994 |
| EPS Basic Total Ops | -1.68 | -2.74 | -3.40 | -4.80 | -5.52 |
| EPS Basic Continuous Ops | -1.70 | -2.74 | -3.46 | -4.75 | -5.50 |
| EPS Diluted Total Ops | -1.68 | -2.74 | -3.40 | -4.80 | -5.52 |
| EPS Diluted Continuous Ops | -1.70 | -2.74 | -3.46 | -4.75 | -5.50 |
| EPS Diluted Before Non-Recurring Items | -1.68 | -2.76 | -3.48 | -4.80 | N/A |
| EBITDA(a) | $-2,540 | $-3,316 | $-3,025 | $-3,609 | $-4,044 |